Looking Back at the Projects We've Had the Opportunity to Support
- Parimer
- 5 days ago
- 4 min read
The other day, we were talking as a team at Parimer about some of the projects we've worked on over the years.
It's a conversation that comes from time to time because the range of technologies we've supported is remarkably broad. Looking back, we've had the opportunity to contribute to projects involving pharmaceuticals, medical devices, biologics, implantable materials, wound care products, consumer health products, specialty materials, and commercial manufacturing programs.
Many of these projects remain confidential, and that's exactly how it should be. Our clients trust us with their intellectual property, their research, and often some of their biggest technical challenges. While we cannot share the details of every project, we can share some of the technologies and product categories we've had the opportunity to support throughout our careers.
Pharmaceutical Development
A significant portion of our experience has involved helping organizations develop pharmaceutical products and the technologies that support them.
Projects have included novel excipients, nanoparticle technologies, drug delivery systems, formulation optimization programs, prodrug development, deuterated compounds, and manufacturing scale-up efforts.
One area where we've spent considerable time is Chitosan. Chitosan is a naturally derived polymer that has applications in pharmaceutical formulations, drug delivery systems, medical devices, wound care products, and specialty materials. The science behind chitosan is fascinating because small differences in material characteristics can significantly impact product performance. We previously discussed some of those considerations in our article, What Is Chitosan? Navigating Applications, Types, and Why Precision Matters.
We've also worked on the commercialization of chitosan materials and the challenges associated with producing consistent, high-quality excipients for regulated applications. You can learn more about that work on our Chitosan product page.
Our therapeutic experience includes glioblastoma therapies, prostate cancer treatments, orphan drug candidates, biologic products, organ transplant materials, and proteomics-related technologies. We've also supported research efforts focused on neurodegenerative diseases, including Parkinson's disease research. One example is our work supporting innovative approaches to Parkinson's disease treatment and development, which is highlighted in the Parkinson's research case study.
Medical Devices, Biomaterials, and Wound Care
Medical devices often require expertise that spans product development, materials science, manufacturing, testing, and regulatory strategy.
Over the years, we've supported projects involving hemostatic devices, De Novo medical devices, implantable technologies, advanced wound care products, and novel medical materials. We've also worked with polyurethane implant materials, bone replacement technologies, implantable biomaterials, and custom medical polymers.
Wound care has been another recurring area of focus. Projects have included sprayable bandages, wound rinse products, advanced wound care technologies, and novel bandage materials designed to improve patient outcomes and simplify treatment.
One example involved supporting the development of sprayable hydrogel technology with Luna Labs. The project combined materials science, product development, and manufacturing considerations to advance an innovative wound care solution. You can read more about that work in the Luna Labs case study.
Commercial Products and Manufacturing
Not every project involves clinical-stage therapeutic or emerging medical technology.
We've also supported organizations developing and manufacturing products already on the market, helping address challenges related to formulation, manufacturing, quality systems, scale-up, and commercialization.
Examples include:
Consumer health products
CBD joint pain formulations
Topical pain relief products
Commercial excipient production
GMP-manufactured products
Long-term manufacturing support programs
Helping products successfully transition from development into manufacturing has been a common theme throughout many of the projects we've supported.
Specialty Materials and Unique Technologies
One of the things that has kept this work interesting over the years is the variety of technologies we've encountered.
In addition to pharmaceutical and medical products, we've worked on nuclear emulsions, specialty materials, advanced polymers, and commercial manufacturing projects that don't fit neatly into a single category.
Nuclear emulsions are a good example. While they are very different from pharmaceutical products or medical devices, they require the same attention to material properties, manufacturing consistency, and product performance. These highly specialized materials have applications in scientific research, particle detection, and advanced imaging technologies. You can learn more about this technology on the Nuclear Emulsion product page.
These types of projects often require a unique combination of scientific problem solving, analytical expertise, and manufacturing knowledge, which is one reason they continue to be some of the most rewarding work we do.
A Common Thread
As we reflected on the projects we've worked on over the years, one thing stood out.
The technologies may be different. The industries may be different. The regulatory pathways may be different.
But the challenge is often the same.
Someone has an innovative product and needs help moving it forward.
Whether the project involves a novel excipient, a glioblastoma therapy, an orphan drug, a De Novo medical device, an organ transplant material, a biologic product, a wound care technology, a specialty material, or a commercial product already on the market, success requires expertise, infrastructure, and experience.
For many organizations, that doesn't mean building a laboratory from scratch. It means gaining access to the scientists, facilities, manufacturing capabilities, quality systems, and regulatory expertise needed to move a project forward.
That's the role we've been fortunate to play throughout our careers, and it's the role we continue to play today.
Comments